X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (626) 626
Publication (114) 114
Conference Proceeding (18) 18
Dissertation (16) 16
Patent (16) 16
Book Chapter (12) 12
Newspaper Article (12) 12
Book / eBook (2) 2
Book Review (2) 2
Magazine Article (2) 2
Data Set (1) 1
Technical Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (252) 252
humans (221) 221
male (136) 136
female (135) 135
middle aged (115) 115
aged (93) 93
adult (84) 84
article (78) 78
abridged index medicus (65) 65
hematology (65) 65
oncology (57) 57
leukemia (55) 55
patients (50) 50
aged, 80 and over (48) 48
analysis (45) 45
treatment outcome (45) 45
cancer (40) 40
research (40) 40
surgery (40) 40
care and treatment (38) 38
animals (35) 35
orthopedics (35) 35
chemotherapy (33) 33
therapy (33) 33
young adult (33) 33
health aspects (32) 32
sport sciences (32) 32
adolescent (31) 31
rehabilitation (29) 29
risk factors (28) 28
diagnosis (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
leukemia, lymphocytic, chronic, b-cell - drug therapy (26) 26
outcomes (26) 26
lymphatic leukemia (25) 25
prognosis (25) 25
usage (24) 24
chronic lymphocytic leukemia (23) 23
hemic and lymphatic diseases (23) 23
mortality (23) 23
pharmacology & pharmacy (22) 22
medicine (21) 21
mutation (21) 21
drug therapy (20) 20
physical medicine and rehabilitation (20) 20
cll (19) 19
india (19) 19
retrospective studies (19) 19
survival (19) 19
follow-up studies (18) 18
proteins (18) 18
rituximab (18) 18
chronic lymphatic leukemia (17) 17
cyclophosphamide (17) 17
management (17) 17
multidisciplinary sciences (17) 17
multivariate analysis (17) 17
patient outcomes (17) 17
rotator cuff (17) 17
antineoplastic agents - therapeutic use (16) 16
expression (16) 16
medical research (16) 16
medicine, general & internal (16) 16
mice (16) 16
transplantation (16) 16
acute lymphatic leukemia (15) 15
chronic lymphocytic-leukemia (15) 15
disease-free survival (15) 15
flow cytometry (15) 15
hematology, oncology and palliative medicine (15) 15
medicine & public health (15) 15
nanoparticles (15) 15
studies (15) 15
blood (14) 14
bone marrow (14) 14
cohort studies (14) 14
lymphocytes b (14) 14
lymphomas (14) 14
minimal residual disease (14) 14
pain (14) 14
philadelphia chromosome (14) 14
prospective studies (14) 14
rats (14) 14
shoulder (14) 14
biochemistry (13) 13
disease (13) 13
leukemia, lymphocytic, chronic, b-cell - pathology (13) 13
medicine, experimental (13) 13
quantum physics (13) 13
risk (13) 13
stem cells (13) 13
tumors (13) 13
tyrosine (13) 13
acute myeloid leukemia (12) 12
adults (12) 12
case report (12) 12
fludarabine (12) 12
genetic aspects (12) 12
leukemia, lymphocytic, chronic, b-cell - genetics (12) 12
myeloid leukemia (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 01/2019, Volume 321, Issue 1, pp. 69 - 79
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 01/2019, Volume 139, Issue 3, pp. 351 - 361
Background: Individuals with type 2 diabetes mellitus are at increased risk for heart failure (HF), particularly those with coexisting atherosclerotic... 
chronic kidney diseases | MORTALITY | cardiovascular disease | heart failure | EVENTS | SAXAGLIPTIN | SITAGLIPTIN | type 2 diabetes mellitus | ASSOCIATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PERIPHERAL VASCULAR DISEASE | Heart failure | Diabetics | Patient outcomes | Kidney diseases | Cardiovascular diseases | Health aspects | Risk factors
Journal Article
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 2, pp. 294 - 302
BACKGROUND Minimal residual disease (MRD) assessment predicts survival for patients with newly diagnosed acute lymphoblastic leukemia (ALL). Its significance... 
relapsed | refractory | inotuzumab | blinatumomab | minimal residual disease | acute lymphoblastic leukemia | ADULT PATIENTS | PROGNOSIS | INOTUZUMAB OZOGAMICIN | ACUTE LYMPHOCYTIC-LEUKEMIA | INDUCTION | TRANSPLANTATION | ONCOLOGY | FLOW-CYTOMETRY | MRD | CLINICAL-SIGNIFICANCE | Neoplasm, Residual - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Young Adult | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Stem Cell Transplantation - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adolescent | Aged, 80 and over | Adult | Aged | B-Lymphocytes - pathology | Hematopoietic Stem Cell Transplantation - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Salvage Therapy - methods | Flow cytometry | Cell survival | Acute lymphatic leukemia | Identification methods | Leukemia | Minimal residual disease | Stem cell transplantation | Transplantation | Lymphatic leukemia | Patients | Survival | Doxorubicin | Vincristine | Cytometry | Cyclophosphamide | Salvage | Lymphocytes B | Stem cells | Remission | Adults | Cancer | Acute lymphoblastic leukemia
Journal Article